(Q42079736)

16 October 2017

title

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

0 references

1 reference

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

10 June 2023

chronic heart failure

1 reference

5

B H Brundage

1 reference

16 October 2017

S. A. Rubin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

K. Chatterjee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

T. A. Ports

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

H. J. Gelberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

W. W. Parmley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A495513

6 July 2022

language of work or name

English

0 references

publication date

1 November 1979

1 reference

full work available at URL

16 October 2017

https://api.elsevier.com/content/article/PII:0002914979901863?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

https://api.elsevier.com/content/article/PII:0002914979901863?httpAccept=text/plain

10 June 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

American Journal of Cardiology

10 June 2023

published in

1 reference

16 October 2017

volume

44

1 reference

16 October 2017

issue

6

1 reference

16 October 2017

page(s)

1183-1189

1 reference

The role of vasodilator therapy in heart failure

16 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Vasodilator treatment for acute and chronic heart failure

10 June 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

10 June 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

10 June 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

10 June 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

10 June 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Enhanced left ventricular performance with phentolamine in acute myocardial infarction.

10 June 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular Failure

10 June 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin

10 June 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Intravenous nitroglycerin in acute myocardial infarction

10 June 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Vasodilator therapy for chronic left ventricular failure

10 June 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure

10 June 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

10 June 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure

10 June 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic effects of nitroglycerin ointment in congestive heart failure

10 June 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

10 June 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise

10 June 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

10 June 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Oral hydralazine therapy for chronic refractory heart failure

10 June 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

10 June 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

10 June 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Beneficial effects of hydralazine in severe mitral regurgitation

10 June 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

10 June 2023

Blood gas calculator

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Micromethod for measuring blood oxygen content by determining oxygen tension after saturation with carbon monoxide

10 June 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

An enzymatic fluorometric method for the determination of lactic acid in serum

10 June 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

The fate of circulating lactic acid in the human lung

10 June 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure

10 June 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Nitroglycerin-induced improvement in exercise tolerance and hemodynamics in patients with chronic rheumatic heart valve disease

10 June 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure

10 June 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle

10 June 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

Cardiocirculatory responses to muscular exercise in congestive heart failure

10 June 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(79)90186-3

10 June 2023

Identifiers

1 reference

16 October 2017

1 reference